InBios International Inc:企業の製品パイプライン分析

◆英語タイトル:InBios International Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME15191PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥162,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥243,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InBios International Inc (InBios International) is a medical device company that develops, manufactures and markets medical diagnostic tests for detecting infectious diseases. The company offers products such as assays, ELISA kits, rapid immunoassays, veterinary products, and monoclonal antibodies. Its services comprise research and development and contract manufacturing. The company’s contract manufacturing services comprise reagent preparation, packaging and kit assembly, assay development, computerized label printing, liquid filling, product and process validation, and others. It markets its products across the US. InBios International is headquartered in Seattle, Washington, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InBios International Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
InBios International Inc Company Overview
InBios International Inc Company Snapshot
InBios International Inc Pipeline Products and Ongoing Clinical Trials Overview
InBios International Inc – Pipeline Analysis Overview
InBios International Inc – Key Facts
InBios International Inc – Major Products and Services
InBios International Inc Pipeline Products by Development Stage
InBios International Inc Pipeline Products Overview
DENV Detect IgA Capture ELISA
DENV Detect IgA Capture ELISA Product Overview
Leprosy Detect ELISA Kit
Leprosy Detect ELISA Kit Product Overview
Malaria Pf/Pv Detect Rapid Test
Malaria Pf/Pv Detect Rapid Test Product Overview
Multiplex Test
Multiplex Test Product Overview
Point-Of-Care Diagnostic Test – Anthrax
Point-Of-Care Diagnostic Test – Anthrax Product Overview
SCoV-2 Ag Detect Rapid Test
SCoV-2 Ag Detect Rapid Test Product Overview
SCoV-2 Detect IgM/IgG Rapid Test
SCoV-2 Detect IgM/IgG Rapid Test Product Overview
Smart Detect SARS-CoV-2 rRT-PCR Kit
Smart Detect SARS-CoV-2 rRT-PCR Kit Product Overview
Strongyloides Detect IgG ELISA
Strongyloides Detect IgG ELISA Product Overview
InBios International Inc – Key Competitors
InBios International Inc – Key Employees
InBios International Inc – Locations And Subsidiaries
Head Office
Recent Developments
InBios International Inc, Recent Developments
Sep 03, 2019: Zika diagnostic test granted market authorization by FDA
May 23, 2019: FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies
Sep 11, 2018: InBios receives FDA Clearance for its DENV Detect NS1 ELISA Test for early detection of Dengue Fever
Sep 26, 2017: HHS advances point-of-care diagnostic test for anthrax
Dec 22, 2016: FDA Warns Health Care Providers Against Relying Solely on Zika Virus Serological IgM Assay Results
Aug 01, 2016: HHS awards $5.1 million to InBios to advance Zika Diagnostic
Apr 08, 2011: Inbios Receives FDA Approval To Market Test To Help Diagnose Dengue Fever
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
InBios International Inc Pipeline Products and Ongoing Clinical Trials Overview
InBios International Inc Pipeline Products by Equipment Type
InBios International Inc Pipeline Products by Indication
InBios International Inc, Key Facts
InBios International Inc, Major Products and Services
InBios International Inc Number of Pipeline Products by Development Stage
InBios International Inc Pipeline Products Summary by Development Stage
DENV Detect IgA Capture ELISA - Product Status
DENV Detect IgA Capture ELISA - Product Description
Leprosy Detect ELISA Kit - Product Status
Leprosy Detect ELISA Kit - Product Description
Malaria Pf/Pv Detect Rapid Test - Product Status
Malaria Pf/Pv Detect Rapid Test - Product Description
Multiplex Test - Product Status
Multiplex Test - Product Description
Point-Of-Care Diagnostic Test - Anthrax - Product Status
Point-Of-Care Diagnostic Test - Anthrax - Product Description
SCoV-2 Ag Detect Rapid Test - Product Status
SCoV-2 Ag Detect Rapid Test - Product Description
SCoV-2 Detect IgM/IgG Rapid Test - Product Status
SCoV-2 Detect IgM/IgG Rapid Test - Product Description
Smart Detect SARS-CoV-2 rRT-PCR Kit - Product Status
Smart Detect SARS-CoV-2 rRT-PCR Kit - Product Description
Strongyloides Detect IgG ELISA - Product Status
Strongyloides Detect IgG ELISA - Product Description
InBios International Inc, Key Employees
Glossary

★海外企業調査レポート[InBios International Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pakistan Services Ltd.
    Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Toyota Industries Corp (6201):企業の財務・戦略的SWOT分析
    Toyota Industries Corp (6201) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Compagnie Generale des Etablissements Michelin:企業の戦略・SWOT・財務情報
    Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report Summary Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • The New York Times Company (NYT):企業の財務・戦略的SWOT分析
    The New York Times Company (NYT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • BTG Plc (BTG):医療機器:M&Aディール及び事業提携情報
    Summary BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for …
  • National Bank of Egypt S.A.E:企業の戦略・SWOT・財務情報
    National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report Summary National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Acasti Pharma Inc (APO):企業の財務・戦略的SWOT分析
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • PolyNovo Ltd (PNV)-製薬・医療分野:企業M&A・提携分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Limited is a medical device company that designs, develops and manufactures solutions for standalone and combination devices. The company offers products such as biodegradable temporizing matrix and negative pressure wound therapy dressing systems. I …
  • Lyft Inc (LYFT):企業の財務・戦略的SWOT分析
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Main Street America Group Inc:企業の戦略的SWOT分析
    Main Street America Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Siegfried Holding AG (SFZN):製薬・医療:M&Aディール及び事業提携情報
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • Cellnovo Ltd-医療機器分野:企業M&A・提携分析
    Summary Cellnovo Ltd (Cellnovo), formerly Starbridge Systems Ltd is a provider of conventional diabetes care technology solutions. The company offers mobile diabetes management system, including an insulin patch pump, activity monitor, cellular-enabled wireless touchscreen handset with integrated bl …
  • GulfMark Offshore Inc (GLF):石油・ガス:M&Aディール及び事業提携情報
    Summary GulfMark Offshore Inc (GulfMark Offshore), formerly New GulfMark Offshore Inc is an oil and gas company that offers oil and gas, and marine transportation services. The company owns, operates, and manages fleet of vessels offering marine specialty services to offshore oil and natural gas dri …
  • Nordstrom, Inc.:企業の戦略・SWOT・財務情報
    Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nordstrom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Recurrent Energy LLC:電力:M&Aディール及び事業提携情報
    Summary Recurrent Energy LLC (Recurrent Energy), a subsidiary of Canadian Solar Inc. is a mainstream clean energy company that operates a portfolio of solar energy projects and generates electricity. The company develops and operates a portfolio of utility scale power projects. It has more than 4 GW …
  • DePuy Synthes Inc:企業の戦略的SWOT分析
    DePuy Synthes Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Humanigen Inc (HGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Humanigen Inc(Humanigen) formerly known as KaloBios Pharmaceuticals Inc, is a development stage biopharmaceutical company that develops medicines for neglected and rare diseases. The company offers benznidazole, a nitroimidazole derivative used for the treatment of Chagas disease, a parasiti …
  • AMC Entertainment Holdings, Inc.:企業の戦略・SWOT・財務分析
    AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Twist Bioscience Corp (TWST):医療機器:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • Hargreaves Lansdown PLC:企業の戦略・SWOT・財務情報
    Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Lansdown PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆